Form 4 for DGX Quest Diagnostics
Accepted 2025-09-25 00:00:00 ET · period of report 2025-09-23 · accession 0001222679-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-25 | 2025-09-23+ | DGX | PREVOZNIK MICHAEL E | SVP, GC | S - Sale+OE | $187.12 | -28.5K | 38.1K | -43% | -$5.33M |
| DM | 2025-09-25 | 2025-09-23+ | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | +28.5K | 38.3K | +290% | +$2.95M |
| DM | 2025-09-25 | 2025-09-23+ | DGX | PREVOZNIK MICHAEL E | SVP, GC | M - OptEx | $103.57 | -28.5K | 227 | -99% | -$2.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-23 | S | D | 28,288 | $187.12 | 38,117 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $187.000 to $187.880. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-09-23 | M | A | 28,288 | $103.57 | 66,405 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-24 | S | D | 175 | $187.02 | 38,117 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $187.000 to $187.350. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-09-24 | M | A | 175 | $103.57 | 38,292 | D | — | — | |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2025-09-23 | M | D | 28,288 | $103.57 | 402 | D | $103.57 · — to 2028-02-19 | 28,288 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021. |
| 6 | Derivative | Non-Qualifed Stock Option (right to buy) | 2025-09-24 | M | D | 175 | $103.57 | 227 | D | $103.57 · — to 2028-02-19 | 175 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021. |